Show simple item record

dc.contributor.authorAral, F
dc.contributor.authorTelci, A
dc.contributor.authorSivas, A
dc.contributor.authorAkcay, T
dc.contributor.authorCakatay, U
dc.contributor.authorKayali, R
dc.date.accessioned2021-03-05T09:09:37Z
dc.date.available2021-03-05T09:09:37Z
dc.date.issued1998
dc.identifier.citationCakatay U., Telci A., Kayali R., Akcay T., Sivas A., Aral F., "Changes in bone turnover on deoxypyridinoline levels in diabetic patients", DIABETES RESEARCH AND CLINICAL PRACTICE, cilt.40, ss.75-79, 1998
dc.identifier.issn0168-8227
dc.identifier.othervv_1032021
dc.identifier.otherav_9c9417a1-26bc-4706-9579-3e9751b31bdc
dc.identifier.urihttp://hdl.handle.net/20.500.12627/105205
dc.identifier.urihttps://doi.org/10.1016/s0168-8227(98)00025-4
dc.description.abstractIn this study, we evaluated bone turnover in 35 patients with non- insulin-dependent diabetes mellitus with no complications and in 35 healthy volunteers who formed the control group and whose ages matched those of the patients. We determined serum osteocalcin (OC) and total alkaline phosphatase levels as markers of bone formation, and urinary deoxypyridinoline (DPD) and urinary calcium levels as markers of bone resorption. Statistical comparison of the levels of these markers between sexes in diabetic and control groups revealed that the OC levels were significantly decreased in males and females in the diabetic group compared with those of the control group. No significant difference was observed for other markers. It was found that the OC levels of diabetic subjects were not affected by the type of therapy. No statistically significant difference was found in serum calcium, phosphorus and magnesium levels between the diabetic and the control groups. In our study, the finding that, in spite of the decrease in the OC levels in the diabetic group no difference was observed in DPD levels, was attributed to the fact that only the formation phase was affected in diabetes, while the resorption phase remained unaltered. (C) 1998 Elsevier Science Ireland Ltd, All rights reserved.
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.titleChanges in bone turnover on deoxypyridinoline levels in diabetic patients
dc.typeMakale
dc.relation.journalDIABETES RESEARCH AND CLINICAL PRACTICE
dc.contributor.department, ,
dc.identifier.volume40
dc.identifier.issue2
dc.identifier.startpage75
dc.identifier.endpage79
dc.contributor.firstauthorID8158


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record